Viewing Study NCT03582033

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2026-02-28 @ 9:37 AM
Study NCT ID: NCT03582033
Status: TERMINATED
Last Update Posted: 2024-12-24
First Post: 2018-06-12
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Safety Study of SEA-BCMA in Patients With Multiple Myeloma
Sponsor: Seagen Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None RRMM View
None Antibodies, monoclonal View
None Antigens, BCMA View
None Immunotherapy View
None Hematologic diseases View
None Myeloma View
None Seattle Genetics View